BETACEFTRAN

This brand name is authorized in Nigeria.

Active ingredients

The drug BETACEFTRAN contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3863	Injection	BETACEFTRAN INJECTION INJ 1 g 1 X 1	89 RNW-PP-313296 BETACEFTRAN INJECTION CEFTRIAXONE SODIUM 1G + WATER FOR INJECTION 10ML Ceftriaxone Sodium 1g, Water for injection 10ml B4-3863 Drugs Imported Products 1x1 Prescription Only Medicine (POM) 2/9/2023 LABETA DRUGS LIMITED, NO 125C OLAITAN STREET, OFF NNOBI STREET, SURULERE LAGOS 18544878 greenabeta_nig@yahoo.com ANHUI CHENGSHI PHARMACEUTICAL CO,. LTD, NO. 5068 HUAISHANG ROAD, BENGBU, ANHUI PROVINCE . CHINA, China	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3863